Basic fibroblast growth factor is neither necessary nor sufficient for the development of retinal neovascularization

Hiroaki Ozaki, Naoyuki Okamoto, Sagrario Ortega, Michelle Chang, Keiko Ozaki, Srinivas Sadda, Melissa A. Vinores, Nancy Derevjanik, Donald J Zack, Claudio Basilico, Peter A Campochiaro

Research output: Contribution to journalArticle

Abstract

Basic fibroblast growth factor (FGF2) is constitutively expressed in the retina and its expression is increased by a number of insults, but its role in the retina is still uncertain. This study was designed to test the hypothesis that altered expression of FGF2 in the retina affects the development of retinal neovascularization. Mice with targeted disruption of the Fgf2 gene had no detectable expression of FGF2 in the retina by Western blot, but retinal vessels were not different in appearance or total area from wild-type mice. When FGF2-deficient mice were compared with wild-type mice in a murine model of oxygen-induced ischemic retinopathy, they developed the same amount of retinal neovascularization. Transgenic mice with a rhodopsin promoter/Fgf2 gene fusion expressed high levels of FGF2 in retinal photoreceptors but developed no retinal neovascularization or other abnormalities of retinal vessels; in the ischemic retinopathy model, they Showed no significant difference in the amount of retinal neovascularization compared with wild-type mice. These data indicate that FGF2 expression is not necessary nor sufficient for the development of retinal neovascularization. This suggests that agents that specifically antagonize FGF2 are not likely to be useful adjuncts in the treatment of retinal neovascularization and therapies designed to increase FGF2 expression are not likely to be complicated by retinal neovascularization.

Original languageEnglish (US)
Pages (from-to)757-765
Number of pages9
JournalAmerican Journal of Pathology
Volume153
Issue number3
StatePublished - Sep 1998

Fingerprint

Retinal Neovascularization
Fibroblast Growth Factor 2
Retina
Retinal Vessels
Vertebrate Photoreceptor Cells
Rhodopsin
Gene Fusion
Transgenic Mice
Western Blotting
Oxygen

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Basic fibroblast growth factor is neither necessary nor sufficient for the development of retinal neovascularization. / Ozaki, Hiroaki; Okamoto, Naoyuki; Ortega, Sagrario; Chang, Michelle; Ozaki, Keiko; Sadda, Srinivas; Vinores, Melissa A.; Derevjanik, Nancy; Zack, Donald J; Basilico, Claudio; Campochiaro, Peter A.

In: American Journal of Pathology, Vol. 153, No. 3, 09.1998, p. 757-765.

Research output: Contribution to journalArticle

Ozaki, H, Okamoto, N, Ortega, S, Chang, M, Ozaki, K, Sadda, S, Vinores, MA, Derevjanik, N, Zack, DJ, Basilico, C & Campochiaro, PA 1998, 'Basic fibroblast growth factor is neither necessary nor sufficient for the development of retinal neovascularization', American Journal of Pathology, vol. 153, no. 3, pp. 757-765.
Ozaki, Hiroaki ; Okamoto, Naoyuki ; Ortega, Sagrario ; Chang, Michelle ; Ozaki, Keiko ; Sadda, Srinivas ; Vinores, Melissa A. ; Derevjanik, Nancy ; Zack, Donald J ; Basilico, Claudio ; Campochiaro, Peter A. / Basic fibroblast growth factor is neither necessary nor sufficient for the development of retinal neovascularization. In: American Journal of Pathology. 1998 ; Vol. 153, No. 3. pp. 757-765.
@article{a440e7147b9148bcb5f6511e1fae4855,
title = "Basic fibroblast growth factor is neither necessary nor sufficient for the development of retinal neovascularization",
abstract = "Basic fibroblast growth factor (FGF2) is constitutively expressed in the retina and its expression is increased by a number of insults, but its role in the retina is still uncertain. This study was designed to test the hypothesis that altered expression of FGF2 in the retina affects the development of retinal neovascularization. Mice with targeted disruption of the Fgf2 gene had no detectable expression of FGF2 in the retina by Western blot, but retinal vessels were not different in appearance or total area from wild-type mice. When FGF2-deficient mice were compared with wild-type mice in a murine model of oxygen-induced ischemic retinopathy, they developed the same amount of retinal neovascularization. Transgenic mice with a rhodopsin promoter/Fgf2 gene fusion expressed high levels of FGF2 in retinal photoreceptors but developed no retinal neovascularization or other abnormalities of retinal vessels; in the ischemic retinopathy model, they Showed no significant difference in the amount of retinal neovascularization compared with wild-type mice. These data indicate that FGF2 expression is not necessary nor sufficient for the development of retinal neovascularization. This suggests that agents that specifically antagonize FGF2 are not likely to be useful adjuncts in the treatment of retinal neovascularization and therapies designed to increase FGF2 expression are not likely to be complicated by retinal neovascularization.",
author = "Hiroaki Ozaki and Naoyuki Okamoto and Sagrario Ortega and Michelle Chang and Keiko Ozaki and Srinivas Sadda and Vinores, {Melissa A.} and Nancy Derevjanik and Zack, {Donald J} and Claudio Basilico and Campochiaro, {Peter A}",
year = "1998",
month = "9",
language = "English (US)",
volume = "153",
pages = "757--765",
journal = "American Journal of Pathology",
issn = "0002-9440",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Basic fibroblast growth factor is neither necessary nor sufficient for the development of retinal neovascularization

AU - Ozaki, Hiroaki

AU - Okamoto, Naoyuki

AU - Ortega, Sagrario

AU - Chang, Michelle

AU - Ozaki, Keiko

AU - Sadda, Srinivas

AU - Vinores, Melissa A.

AU - Derevjanik, Nancy

AU - Zack, Donald J

AU - Basilico, Claudio

AU - Campochiaro, Peter A

PY - 1998/9

Y1 - 1998/9

N2 - Basic fibroblast growth factor (FGF2) is constitutively expressed in the retina and its expression is increased by a number of insults, but its role in the retina is still uncertain. This study was designed to test the hypothesis that altered expression of FGF2 in the retina affects the development of retinal neovascularization. Mice with targeted disruption of the Fgf2 gene had no detectable expression of FGF2 in the retina by Western blot, but retinal vessels were not different in appearance or total area from wild-type mice. When FGF2-deficient mice were compared with wild-type mice in a murine model of oxygen-induced ischemic retinopathy, they developed the same amount of retinal neovascularization. Transgenic mice with a rhodopsin promoter/Fgf2 gene fusion expressed high levels of FGF2 in retinal photoreceptors but developed no retinal neovascularization or other abnormalities of retinal vessels; in the ischemic retinopathy model, they Showed no significant difference in the amount of retinal neovascularization compared with wild-type mice. These data indicate that FGF2 expression is not necessary nor sufficient for the development of retinal neovascularization. This suggests that agents that specifically antagonize FGF2 are not likely to be useful adjuncts in the treatment of retinal neovascularization and therapies designed to increase FGF2 expression are not likely to be complicated by retinal neovascularization.

AB - Basic fibroblast growth factor (FGF2) is constitutively expressed in the retina and its expression is increased by a number of insults, but its role in the retina is still uncertain. This study was designed to test the hypothesis that altered expression of FGF2 in the retina affects the development of retinal neovascularization. Mice with targeted disruption of the Fgf2 gene had no detectable expression of FGF2 in the retina by Western blot, but retinal vessels were not different in appearance or total area from wild-type mice. When FGF2-deficient mice were compared with wild-type mice in a murine model of oxygen-induced ischemic retinopathy, they developed the same amount of retinal neovascularization. Transgenic mice with a rhodopsin promoter/Fgf2 gene fusion expressed high levels of FGF2 in retinal photoreceptors but developed no retinal neovascularization or other abnormalities of retinal vessels; in the ischemic retinopathy model, they Showed no significant difference in the amount of retinal neovascularization compared with wild-type mice. These data indicate that FGF2 expression is not necessary nor sufficient for the development of retinal neovascularization. This suggests that agents that specifically antagonize FGF2 are not likely to be useful adjuncts in the treatment of retinal neovascularization and therapies designed to increase FGF2 expression are not likely to be complicated by retinal neovascularization.

UR - http://www.scopus.com/inward/record.url?scp=0031659904&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031659904&partnerID=8YFLogxK

M3 - Article

VL - 153

SP - 757

EP - 765

JO - American Journal of Pathology

JF - American Journal of Pathology

SN - 0002-9440

IS - 3

ER -